Donald Trump scripted a decisive victory in the Iowa caucuses, cementing his status as the frontrunner for the 2024 Republican presidential nomination, a contest that also saw Indian-American......
Indian-American entrepreneur-turned-politician Vivek Ramaswamy on Monday suspended his presidential campaign following his poor showing in the Iowa Caucus and announced his endorsement of its......
Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
A parliamentary committee has stressed the urgent need to evolve strategies for development of next-generation vaccines and recommended that the Union health ministry encourage vaccine development......
Calling her “fascist” and “corrupt,” biotech entrepreneur Vivek Ramaswamy launched a tirade against his Republican presidential rival and fellow Indian-American Nikki Haley,......
'Fundamentally, we think that in the coming quarters, API business should come back.' Photograph: Kind courtesy Biocon Biocon is preparing to make the most of the peptides opportunity as these......
'There is no reason why we should break this business up.' Photograph: Kind courtesy Biocon Bengaluru-headquartered biotech major Biocon has been working to reduce its cumulative debt of around......
Domestic mutual funds (MFs) have underpinned demand for most public floats this year, dominated by small- and mid-sized initial public offerings (IPOs). Illustration: Dominic Xavier/Rediff.com Of......
Notwithstanding the ongoing decline in equity markets week after week, August has proven to be the most successful since December for initial public offerings (IPOs). Illustration: Dominic......
Catamaran, the family office of Infosys founder Narayana Murthy, is targeting 15 per cent returns on its portfolio investments per annum as it shifts focus from early-stage investments to growth......
IMAGE: The biotech firm, in which Novak Djokovic has an 80 per cent stake, has around 11 researchers working in Denmark, Australia and Slovenia, working on a treatment and not a vaccine according......